Delivery Order SPE2DB20D1109-SPE2DB23FN40H
Award Date 1/25/23
Potential Completion Date 1/26/23
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Quillivant XR 25 mg/5 ml suspension, a 150 ml medication. The contract has a ceiling value of $1,567.76 and runs through December 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization and the parent company. The contract is a delivery order under a larger Indefinite Delivery Contract...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, valued at $1,477.70, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range...
- This federal contract award, valued at $1,328.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The award has an ultimate completion date of February 15, 2024, and is a firm fixed-price delivery order contract. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Quillivant XR oral suspension, a pharmaceutical product. The contract, valued at $3,199.60, is a delivery order with a firm fixed price under the Defense Logistics Agency (DLA) Troop Support Medical's Indefinite Delivery Contract (IDC) worth up to $999,999,999.00. The contract has no set-aside designation, indicating open competition. Amerisourcebergen, as a major pharmaceutical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price valued at $2,025.20 for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The award has an ultimate completion date of February 5, 2024. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor and healthcare solutions provider, plays a critical...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension (180 ml) to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $4,747.53, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,315.96 issued by the Defense Logistics Agency (DLA) for the provision of Quillivant XR 25 mg/5 ml suspension medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of Quillivant XR 25 mg/5 ml suspension medication to support various government healthcare programs. The $3,943.20 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $1,065.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order (SPE2DB22FJ3G7) for the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, with a completion date of March 31, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,070.38 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which has a period of performance through May 19, 2023, is for the supply of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension in a 120 ml container. The contract is a firm fixed-price arrangement and does not have a small business set-aside designation, indicating it was...